Burning Rock Biotech Limited
BNR | NASDAQ
$14.73
+$0.50 (+3.48%)
At close: Sep 21, 2026, 4:00 PM ET
$14.73
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 539.57M | 515.82M | 537.44M | 563.24M | 507.86M | 429.9M |
Cost of Revenue | 136.65M | 153.42M | 174.21M | 183.2M | 143.72M | 115.98M |
Gross Profit | 402.91M | 362.4M | 363.23M | 380.04M | 364.15M | 313.92M |
Operating Income | -54.85M | -357.56M | -669.32M | -980.41M | -797.06M | -412.41M |
Interest Income | 8.05M | 12.21M | 17.96M | 9.46M | 3.46M | 6.07M |
Pretax Income | -53.79M | -340.74M | -651.3M | -969.25M | -795.8M | -407.24M |
Net Income | -55.35M | -346.63M | -653.69M | -971.23M | -796.7M | -407.24M |
Selling & General & Admin | 291.27M | 452.54M | 685.53M | 938.58M | 793.35M | 462.39M |
Research & Development | 166.49M | 232.29M | 347.02M | 421.87M | 367.86M | 263.94M |
Other Expenses | n/a | 35.13M | n/a | n/a | n/a | n/a |
Operating Expenses | 457.76M | 719.96M | 1.03B | 1.36B | 1.16B | 726.33M |
Interest Expense | 30K | n/a | n/a | n/a | 1.54M | 667K |
Selling & Marketing Expenses | 165.18M | 190.9M | 247.71M | 370.29M | 303.1M | 168.59M |
Cost & Expenses | 594.41M | 873.38M | 1.21B | 1.54B | 1.3B | 842.31M |
Income Tax Expense | 1.56M | 5.89M | 2.39M | 1.99M | 899K | n/a |
Shares Outstanding (Basic) | 1.08M | 10.29M | 10.24M | 10.39M | 10.42M | 5.92M |
Shares Outstanding (Diluted) | 1.08M | 10.29M | 10.24M | 10.39M | 10.42M | 6.86M |
EPS (Basic) | -49.60 | -33.67 | -63.84 | -93.47 | -76.45 | -68.76 |
EPS (Diluted) | -49.60 | -33.67 | -63.84 | -93.47 | -76.45 | -68.76 |
EBITDA | -32M | -270.23M | -517.9M | -845.15M | -746.5M | -373.26M |
EBIT | -53.76M | -322.43M | -651.3M | -969.25M | -794.26M | -406.57M |
Depreciation & Amortization | 21.76M | 52.2M | 133.4M | 124.1M | 47.77M | 33.31M |
Add to Watchlist
Select watchlists to add or remove BNR